Almost 95 billion dollars of lost earnings. That’s the estimated price USA paid in 2015 for cancer-related deaths in people aged 16 to 84 years, according to a paper recently published in JAMA Oncology by [more]
As a journalist, I often wonder about the exact location of the fine line that separates justified enthusiasm from self-serving hype, especially when it comes to clinical trials. Last week, I asked the question of [more]
In the last decade, cancer cases increased worldwide by 33 percent, mostly due to population aging, population growth and changes in age-specific cancer rates: this is one of the key conclusions of the new report [more]